Mirion Technologies, Inc. (MIR)

9,94 -0,26 (-2,55%) Alla chiusura: 04:00PM EDT

Mirion Technologies, Inc.

1218 Menlo Drive
Atlanta, GA 30318
United States
770 432 2744
https://www.mirion.com

Settore/i: Industrials
Settore: Specialty Industrial Machinery
Impiegati a tempo pieno: 2.800

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Thomas D. Logan	Founder, Medical Group President, CEO & Director	1,87M	N/D	1961
Mr. Brian Schopfer	Chief Financial Officer	1,14M	N/D	1985
Mr. Loic Eloy	Group President of Technologies	626,84k	N/D	1977
Mr. Christopher Moore CPA	Chief Accounting Officer & Principal Accounting Officer	N/D	N/D	1972
Mr. James Cocks	Chief Technology Officer	N/D	N/D	N/D
Mr. Alex Gaddy	SVP of Strategy, IR & Treasurer	N/D	N/D	N/D
Ms. Emmanuelle Lee	Executive VP, General Counsel, Secretary & Chief Legal Officer	N/D	N/D	N/D
Erin Schesny	Chief Marketing Officer	N/D	N/D	N/D
Ms. Alison Ulrich	Chief Human Resources Officer	N/D	N/D	N/D
Mr. Bertrand Duban	President of Nuclear Medicine	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Governance aziendale

L'ISS Governance QualityScore di Mirion Technologies, Inc. al 1 maggio 2024 è 4. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 5; diritti degli azionisti: 6; retribuzione: 4.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.